Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008

200720062004

Oct 2, 2017
--Company Cleared to Market Prescription and OTC Generic Prevacid®--

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Lansoprazole...

More
Sep 27, 2017

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Oxycodone and...

More
Sep 26, 2017

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Dexmethylphenidate...

More
Sep 26, 2017

Lannett Company, Inc. (NYSE: LCI) today announced that the United States District Judge for the Eastern District of Pennsylvania dismissed in its entirety a putative class action lawsuit against a...

More
Sep 25, 2017
--CEO Arthur Bedrosian to Step Down Upon Naming of a Successor--

Lannett Company, Inc. (NYSE: LCI) today announced that its board of directors has begun a search for a new chief executive officer (CEO). As part of the unanimously approved search process, the...

More
Sep 22, 2017

Arthur Bedrosian, chief executive officer of Lannett Company, Inc. (NYSE: LCI), has prevailed in his lawsuit with the U.S. Internal Revenue Service (IRS). Bedrosian filed a lawsuit against the...

More
Sep 5, 2017

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Esomeprazole...

More
Aug 23, 2017

Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2017 fourth quarter and full year ended June 30, 2017. "In the coming year, we expect a solid increase in net...

More
Aug 8, 2017
--Company to Report Full Financial Results and Host Conference Call on August 23--

Lannett Company, Inc. (NYSE: LCI) today reported preliminary financial results for its fiscal 2017 fourth quarter and full year ended June 30, 2017. "While our industry is currently facing...

More
Aug 1, 2017

Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the Canaccord Genuity 37th Annual Growth Conference on August 9, 2017 at 4 p.m. (ET) at the InterContinental Hotel in

More
 

print email rss
Lannett Investor Relations
Lannett Company Products